Upgrade to SI Premium - Free Trial

UPDATE: JPMorgan Downgrades Neurocrine Bio. (NBIX) to Neutral

August 4, 2020 4:17 AM
(Updated - August 4, 2020 4:58 AM EDT)

(updating comment)JPMorgan analyst Anupam Rama downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades

Next Articles